Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-23-027226

EVP, Corp Strategy & Develop sold 9,128 shares at an average $173.48 ($1,583,522)

  • EVP, Corp Strategy & Develop acquired 9,128 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LaPlume Joseph W EVP, Corp Strategy & Develop 2023-11-09 Option exercise +9,128 $144.67 $1,320,548 34,111 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2023-11-09 Sale −2,585 $172.77 $446,610 31,526 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2023-11-09 Sale −6,543 $173.76 $1,136,912 24,983 D
Derivatives
LaPlume Joseph W EVP, Corp Strategy & Develop 2023-11-09 Option exercise · Stock Options (Right to Buy) −9,128 0 D
Open-market sales · 9,128 sh · avg $173.48 · $1,583,522
Loading xslF345X05/form4.xml…